Step by Step

INTRODUCTION

ABIM MOC Activity ID

11/28/23 - MGR: Bench to Bedside Hypertrophic cardiomyopathy: a journey from the patients bedside to the laboratory bench

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

    • Improve the diagnosis and risk stratification of adult patients with hypertrophic cardiomyopathy.
    • Increase the genetic screening of patients with hypertrophic cardiomyopathy to facilitate accurate diagnosis. 
    • Recommend screening of the family members of hypertrophic cardiomyopathy to reduce cardiovascular risk.
    • Explain the diagnosis and pathophysiology of hypertrophic cardiomyopathy
    • Recognize both knowledge and treatment gaps for obstructive and nonobstructive forms of HCM

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

  1. Ommen S, Mital S, Burke M, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2020 Dec, 76 (25) e159–e240. https://doi.org/10.1016/j.jacc.2020.08.045
  2. Marian AJ and Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017;121:749-770.
  3. Seidman CE, Seidman JG. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res. 2011;108(6):743-50.


Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician (CME)

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™.Each physician should only claim credit commensurate with the extent of their participation in the activity.


Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Timothy Wong, MD, MS — Assistant Professor of Medicine, Director, UPMC Hypertrophic Cardiomyopathy Center; Associate Director, UPMC Cardiovascular Magnetic Resonance Center, University of Pittsburgh School of Medicine
Dr. Wong is the site principal investigator for trials sponsored by Bristol Myers Squibb, Cytokinetics, and Tenaya Therapeutics.
Jason Becker, MD — Associate Professor of Medicine, Division of Cardiology, University of Pittsburgh School of Medicine
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.